{"url_path":"/sec/nxtc/8-k/2026-06-01/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 ****Financial Statements and Exhibits**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/1661059/0001104659-26-068604-index.html","accession_number":"0001104659-26-068604","cik":"0001661059","ticker":"NXTC","issuer_name":"NextCure, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1661059/0001104659-26-068604-index.html","primary_entity_key":"0001661059","primary_entity_name":"NextCure, Inc."},"word_count":110,"has_tables":true,"body_markdown":"**Item 9.01****Financial Statements and Exhibits**\n\n​\n\n(d) Exhibits\n\n​\n\n**Exhibit No. Description**\n\n[99.1](nxtc-20260601xex99d1.htm)****[Press Release issued by NextCure, Inc. dated June 1, 2026](nxtc-20260601xex99d1.htm)\n\n[99.2](nxtc-20260601xex99d2.htm) [ASCO 2026 Poster dated June 1, 2026](nxtc-20260601xex99d2.htm)\n\n[99.3](nxtc-20260601xex99d3.htm) [NextCure, Inc. Presentation dated June 1, 2026](nxtc-20260601xex99d3.htm)****\n\n104 Cover Page Interactive Data File (formatted as inline XBRL).\n\n​\n\n​\n\n​\n\n​\n\n​\n\n**SIGNATURE**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\nNovember\n\nDated: June 1, 2026\n\n**NEXTCURE, INC.**\n\n​\n\n \n\n \n\n \n\n \n\nBy:\n\n/s/ Steven P. Cobourn\n\n \n\nName:\n\nSteven P. Cobourn\n\n \n\nTitle:\n\nChief Financial Officer\n\n​\n\n​\n\n​\n\n​\n\n​"}